ESC 365 - LDL-C: The race to the bottom

ESC Premium Access

LDL-C: The race to the bottom

Session: Insights and innovation - Can we alter the course of atherosclerotic cardiovascular disease?

Topic: Epidemiology, Prognosis, Outcome

Speaker: Professor E. Braunwald (Boston, US)

Sponsored by the Medicines Company

Event: ESC Congress 2019

Congress Presentation

About the speaker

Professor Eugene Braunwald

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

36 presentations

6 followers

5 more presentations in this session

Introduction and purpose

Speaker: Doctor B. Berkowitz (New York, US)

RNA interference - Building oligonucleotides as therapeutics

Speaker: Mr D. Corey (Dallas, US)

Cumulative exposure - Estimating the benefits of intervention

Speaker: Professor B. Ference (Cambridge, GB)

With recent news - here's what's possible

Speaker: Professor J. Kastelein (Amsterdam, NL)

Panel and audience questions and answers

Speaker: Doctor B. Berkowitz (New York, US)

Access the full session

Insights and innovation - Can we alter the course of atherosclerotic cardiovascular disease?

Speakers: Professor E. Braunwald, Doctor B. Berkowitz, Mr D. Corey, Professor B. Ference, Professor J. Kastelein...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

Related content

Open Access

Mode of intervention in aortic stenosis.

28 August 2021

ESC Premium Access

Cardiovascular benefit of lowering LDL-C below 1 mmol/L (40 mg/dl)

28 August 2021

ESC Premium Access

Will coronary atherosclerosis be eliminated?

27 August 2021

ESC 365 is supported by